| 会社名 | Group | 親会社 | 子会社 | 得意先 | 仕入先 | 業務提携 | 銀行等 | 株主等 |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
| HYPHEN BioMed | ||||||||
| Abaxis | ||||||||
| Eurolyser | ||||||||
| Fuji | ||||||||
| Helena | ||||||||
| Optimedical | ||||||||
|
|
||||||||
| RAL Diagnostics | ||||||||
| Tosoh |
Sysmex führt die HISCL™ Plattform für schnelle, skalierbare Blutanalysen zur Alzheimerkrankheit ein. Unabhängige europäische Studien bestätigten für HISCL™ p-Tau217 RUO und das HISCL™ Aβ42/40-Verhältnis eine hohe Genauigkeit bei der frühen Erkennung von Aβ-Pathologie. Die Ergebnisse liegen nach einer routinemäßigen Blutentnahme in 17 Minuten vor.
Sysmex Austria GmbH wurde im Rahmen der LEADING EMPLOYERS 2026-Metastudie als einer der Top 1 % Arbeitgeber in Österreich ausgezeichnet. Die Metastudie kombiniert unterschiedliche Perspektiven, statt sich auf einzelne Quellen zu stützen.
Sysmex Austria hat erfolgreich die ISO-27001:2022-Zertifizierung erhalten. Die Zertifizierung steht für das Engagement des Unternehmens für Datenschutz, Sicherheit und Vertrauen gegenüber Mitarbeitenden, Kunden und Partnern.
The Sysmex PA-100 AST System reduces the time for UTI diagnosis to just 15 minutes and determines optimal antibiotics within 30 minutes, delivering actionable results in 45 minutes. This technology redefines the standard of care for diagnosing and treating uncomplicated urinary tract infections by eliminating delays associated with traditional laboratory testing.
Sysmex Europe SE announced the launch of a fully automated stool analysis solution, expanding its FIT DX™ Series portfolio. The solution is intended to support greater efficiency and scalability in colorectal cancer screening.
OGT announced the launch of its updated SureSeq CLL + CNV V3 NGS panel. The panel uses OGT’s proprietary bait designs to provide broader coverage of disease-associated genes and enhanced CNV detection, enabling more comprehensive variant detection.
Sysmex announced that its subsidiary Sysmex Astrego AB was awarded the Longitude Prize on AMR. The prize recognizes the development of the PA-100 AST System, a rapid antimicrobial susceptibility testing system.
Sysmex Europe SE announced the establishment of a new branch office, Sysmex Nordic ApS, in Finland to strengthen its market presence in Scandinavia. The move aims to expand sales and support networks in the region. Finland’s modern healthcare system and recent reforms favor innovative medical solutions, emphasizing accurate diagnostics.
Sysmex Corporation and CellaVision AB entered into a strategic alliance to advance hematology solutions and expand their portfolio, including next-generation cell morphology analyzers. The companies will work to improve testing workflow efficiency and standardization, increase the precision of cell morphology classification, and provide value in diagnostic support.
Sysmex Corporation will begin providing direct sales and service in Italy for hematology, urinalysis, and hemostasis, in addition to its existing services in life science and industrial flow cytometry. The company aims to grow its market share across test fields and address healthcare providers’ needs through direct communication with customers.